Rates of diagnosis of psychiatric disorders in children have shot up in recent years. So too has the prescription of antidepressant and antipsychotic drugs and stimulants. Yet the diagnoses are based on weak science, questionable research and powerful financial incentives. Sami Timimi questions why.